Lp(a) Drugs: $1.4 Billion Market in 2026?
New drugs target Lp(a), a genetic heart risk affecting 1 in 5 people. Will they gain approval, and how will pricing impact a potential $1.4B market?
New drugs target Lp(a), a genetic heart risk affecting 1 in 5 people. Will they gain approval, and how will pricing impact a potential $1.4B market?
Pelacarsen's trial failed despite lowering Lp(a). Does this mean the strategy is flawed? Learn why reducing Lp(a) alone may not be enough.
Cardiovascular disease kills 19.8M annually. See how $1.8B funding targets AI, precision drugs, and prevention to reshape heart health.
China's AI defense push aims for 'intelligentized' warfare by 2027. Understand the ethical debate & global security impact.
Can AI end financial shame by 2026? See how AI personal finance tools offer judgment-free support for debt and spending, and what to watch for.
New drugs targeting Lp(a) could arrive by 2027. Understand this genetic heart risk factor, why guidelines now recommend testing, and what's next.
We are not ready for the next Ebola outbreak. Learn why global health funding is 40% short and what critical steps are missing for preparedness.
AI predicts your cash flow with 90% accuracy. See how AI manages money, cuts costs, and makes investing accessible for you.
The AI arms race needs urgent regulation. Learn why new laws, like the EU AI Act by 2027, are critical to control powerful AI and ensure safety.
AI personalizes finance, from budgeting to retirement. See how AI tools like robo-advisors cut fees (0.25%) and boost security for your wealth.